These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10424432)

  • 1. Effects of mitogen-activated protein kinase inhibitors or phosphodiesterase inhibitors on interleukin-1-induced cytokines production in synovium-derived cells.
    Tsuji F; Oki K; Senda T; Horiuchi M; Mita S
    Immunol Lett; 1999 Jun; 68(2-3):275-9. PubMed ID: 10424432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential modulation of cytokine production by drugs: implications for therapy in heart failure.
    Matsumori A; Ono K; Sato Y; Shioi T; Nose Y; Sasayama S
    J Mol Cell Cardiol; 1996 Dec; 28(12):2491-9. PubMed ID: 9004165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective type IV phosphodiesterase inhibitors prevent IL-4-induced IgE production by human peripheral blood mononuclear cells.
    Coqueret O; Boichot E; Lagente V
    Clin Exp Allergy; 1997 Jul; 27(7):816-23. PubMed ID: 9249275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cAMP-phosphodiesterase isozyme inhibitor on cytokine production by lipopolysaccharide-stimulated human peripheral blood mononuclear cells.
    Yoshimura T; Kurita C; Nagao T; Usami E; Nakao T; Watanabe S; Kobayashi J; Yamazaki F; Tanaka H; Nagai H
    Gen Pharmacol; 1997 Oct; 29(4):633-8. PubMed ID: 9352314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of insulin-like growth factor binding protein-1 synthesis by interleukin-1beta: requirement of the mitogen-activated protein kinase pathway.
    Frost RA; Nystrom GJ; Lang CH
    Endocrinology; 2000 Sep; 141(9):3156-64. PubMed ID: 10965886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct roles for p42/p44 and p38 mitogen-activated protein kinases in the induction of IL-2 by IL-1.
    Matthews JS; O'Neill LA
    Cytokine; 1999 Sep; 11(9):643-55. PubMed ID: 10479400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin-1 stimulates proinflammatory cytokine expression in human periodontal ligament cells via mitogen-activated protein kinase pathway.
    Liang L; Yu J; Zhou W; Liu N; E LL; Wang DS; Liu H
    J Periodontol; 2014 Apr; 85(4):618-26. PubMed ID: 23701479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteolin suppresses IL-1beta-induced cytokines and MMPs production via p38 MAPK, JNK, NF-kappaB and AP-1 activation in human synovial sarcoma cell line, SW982.
    Choi EM; Lee YS
    Food Chem Toxicol; 2010 Oct; 48(10):2607-11. PubMed ID: 20600535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells.
    Leonard M; Ryan MP; Watson AJ; Schramek H; Healy E
    Kidney Int; 1999 Oct; 56(4):1366-77. PubMed ID: 10504489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A specific inhibitor of the p38 mitogen activated protein kinase affects differentially the production of various cytokines by activated human T cells: dependence on CD28 signaling and preferential inhibition of IL-10 production.
    Koprak S; Staruch MJ; Dumont FJ
    Cell Immunol; 1999 Mar; 192(2):87-95. PubMed ID: 10087176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The differential role of extracellular signal-regulated kinases and p38 mitogen-activated protein kinase in eosinophil functions.
    Adachi T; Choudhury BK; Stafford S; Sur S; Alam R
    J Immunol; 2000 Aug; 165(4):2198-204. PubMed ID: 10925307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNF alpha generation from human monocytes by interacting with a 'low-affinity' phosphodiesterase 4 conformer.
    Souness JE; Griffin M; Maslen C; Ebsworth K; Scott LC; Pollock K; Palfreyman MN; Karlsson JA
    Br J Pharmacol; 1996 Jun; 118(3):649-58. PubMed ID: 8762090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of rolipram-sensitive cyclic AMP phosphodiesterase in the regulation of cardiac contraction.
    Muller B; Lugnier C; Stoclet JC
    J Cardiovasc Pharmacol; 1990 Nov; 16(5):796-803. PubMed ID: 1703603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential inhibition of human neutrophil functions. Role of cyclic AMP-specific, cyclic GMP-insensitive phosphodiesterase.
    Wright CD; Kuipers PJ; Kobylarz-Singer D; Devall LJ; Klinkefus BA; Weishaar RE
    Biochem Pharmacol; 1990 Aug; 40(4):699-707. PubMed ID: 1696820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine-suppressive anti-inflammatory drugs (CSAIDs) inhibit invasion and MMP-1 production of ovarian carcinoma cells.
    Denkert C; Koch I; Berger S; Köbel M; Siegert A; Hauptmann S
    Cancer Lett; 2003 May; 195(1):101-9. PubMed ID: 12767518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SB202190, a selective inhibitor of p38 mitogen-activated protein kinase, is a powerful regulator of LPS-induced mRNAs in monocytes.
    Manthey CL; Wang SW; Kinney SD; Yao Z
    J Leukoc Biol; 1998 Sep; 64(3):409-17. PubMed ID: 9738669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p38 Mitogen-activated protein kinase regulates IL-8 expression in human pulmonary vascular endothelial cells.
    Hashimoto S; Matsumoto K; Gon Y; Maruoka S; Takeshita I; Hayashi S; Koura T; Kujime K; Horie T
    Eur Respir J; 1999 Jun; 13(6):1357-64. PubMed ID: 10445612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of p38 mitogen-activated protein kinase in IL-6 and IL-8 production from the TNF-alpha- or IL-1beta-stimulated rheumatoid synovial fibroblasts.
    Suzuki M; Tetsuka T; Yoshida S; Watanabe N; Kobayashi M; Matsui N; Okamoto T
    FEBS Lett; 2000 Jan; 465(1):23-7. PubMed ID: 10620700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of pig aortic smooth muscle cell DNA synthesis by selective type III and type IV cyclic AMP phosphodiesterase inhibitors.
    Souness JE; Hassall GA; Parrott DP
    Biochem Pharmacol; 1992 Sep; 44(5):857-66. PubMed ID: 1326964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MAP kinase inhibitors, PD098059, UO126 and SB203580, inhibit IL-1beta-dependent PGE(2) release via mechanistically distinct processes.
    Newton R; Cambridge L; Hart LA; Stevens DA; Lindsay MA; Barnes PJ
    Br J Pharmacol; 2000 Jul; 130(6):1353-61. PubMed ID: 10903976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.